[{"NetIncomeLoss_1_Q3_USD":-12949000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":33535829.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":49264938.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_3_Q3_USD":-0.9,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q3_USD":-0.26,"CommitmentsAndContingencies_0_Q3_USD":null,"InterestIncomeOther_3_Q3_USD":276000.0,"InterestIncomeOther_1_Q3_USD":127000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":4432000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-24000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":3196000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-256348000.0,"Depreciation_1_Q3_USD":64000.0,"AssetsCurrent_0_Q3_USD":293242000.0,"OperatingLeaseExpense_3_Q3_USD":66000.0,"OperatingLeaseExpense_1_Q3_USD":22000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":19436710.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":8517684.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":37000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-24000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":9000.0,"Depreciation_3_Q3_USD":194000.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":7292000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":23101000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":9880000.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":200000000.0,"CommonStockValue_0_Q3_USD":5000.0,"OtherNonoperatingIncome_3_Q3_USD":276000.0,"OtherNonoperatingIncome_1_Q3_USD":127000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":855000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":186091000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q3_USD":1548000.0,"ConversionOfStockSharesIssued1_3_Q3_shares":1.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":17400000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-30141000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-12940000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1103000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.0001,"OtherAssetsNoncurrent_0_Q3_USD":295000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":10571000.0,"Liabilities_0_Q3_USD":9049000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":3297000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":124000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":173000.0,"CommonStockSharesIssued_0_Q3_shares":49295840.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":9000.0,"StockholdersEquity_0_Q3_USD":285399000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":589000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-64264000.0,"MarketableSecurities_0_Q3_USD":279913000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-94345000.0,"CommonStockSharesOutstanding_0_Q3_shares":49295840.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":273159000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":624000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-24088000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":295000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":170100000.0,"AccountsPayableCurrent_0_Q3_USD":2292000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":2758000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":67000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":361000.0,"AdditionalPaidInCapital_0_Q3_USD":349682000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":911000.0,"NetIncomeLoss_3_Q3_USD":-30117000.0,"LiabilitiesCurrent_0_Q3_USD":8754000.0,"Assets_0_Q3_USD":294448000.0,"ProfitLoss_3_Q3_USD":-30117000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.9,"ShareBasedCompensation_3_Q3_USD":2531000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1951000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"CommonStockSharesAuthorized_0_Q3_shares":1000000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q3_USD":0.0,"OperatingIncomeLoss_3_Q3_USD":-30393000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.26,"OperatingIncomeLoss_1_Q3_USD":-13076000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":294448000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2030000.0,"PreferredStockSharesAuthorized_0_Q3_shares":200000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":2531000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1548000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":1535000.0,"OperatingExpenses_3_Q3_USD":30393000.0,"OperatingExpenses_1_Q3_USD":13076000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":186148000.0,"ConversionOfStockAmountConverted1_3_Q3_USD":160214000.0,"Ticker":"EWTX","CIK":"1710072","name":"EDGEWISE THERAPEUTICS, INC.","OfficialName":"Edgewise Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"388173759.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]